Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
224
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Healthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

Ashley Kim1 The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy and The Department of Health Services and Economics, University of Washington, Seattle, WA, USA;2 Allergan, an AbbVie company, Irvine, CA, USA;3 GRAIL, Inc, Menlo Park, CA, USACorrespondence[email protected]
View further author information
,
Beth Devine1 The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy and The Department of Health Services and Economics, University of Washington, Seattle, WA, USAORCID Iconhttps://orcid.org/0000-0001-9945-6099View further author information
ORCID Icon,
Joanna Campbell2 Allergan, an AbbVie company, Irvine, CA, USAView further author information
,
Elaheh Shirneshan2 Allergan, an AbbVie company, Irvine, CA, USAView further author information
,
Changgeng Zhao2 Allergan, an AbbVie company, Irvine, CA, USAView further author information
&
Aasthaa Bansal1 The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy and The Department of Health Services and Economics, University of Washington, Seattle, WA, USAView further author information
Pages 2643-2651 | Published online: 23 Jun 2021

References

  • Chakravarthy U, Bailey CC, Johnston RL, et al. Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(6):842–849. doi:10.1016/j.ophtha.2017.11.036
  • Merck. Age-related macular degeneration. The Merck Manual. Available from: https://www.merckmanuals.com/professional/eye-disorders/retinal-disorders/age-related-macular-degeneration-amd-or-armd. Accessed September 9, 2018.
  • Hernández-Zimbrón LF, Zamora-Alvarado R, Ochoa-de la Paz L, et al. Age-related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev. 2018;2018:8374647. doi:10.1155/2018/8374647
  • Lanchoney DM. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients. Arch Ophthalmol. 1998;116(8):1045. doi:10.1001/archopht.116.8.1045
  • Sunness JS, Rubin GS, Zuckerbrod A, Applegate CA. Foveal-sparing scotomas in advanced dry age-related macular degeneration. J Vis Impair Blind. 2008;102(10):600–610. doi:10.1177/0145482x0810201004
  • Fleckenstein M, Mitchell P, Freund KB, et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(3):369–390. doi:10.1016/j.ophtha.2017.08.038
  • Sunness JS, Rubin GS, Applegate CA, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology. 1997;104(10):1677–1691. doi:10.1016/s0161-6420(97)30079-7
  • American Academy of Ophthalmology. Retina/vitreous panel: preferred practice pattern guidelines: age-related macular degeneration; 2015. Available from: https://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp. Accessed September 9, 2018.
  • Coleman AL, Yu F, Ensrud KE, et al. Impact of age-related macular degeneration on vision-specific quality of life: follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. Am J Ophthalmol. 2010;150(5):683–691. doi:10.1016/j.ajo.2010.05.030
  • Xu K, Gupta V, Bae S, Sharma S. Metamorphopsia and vision-related quality of life among patients with age-related macular degeneration. Can J Ophthalmol. 2018;53(2):168–172. doi:10.1016/j.jcjo.2017.08.006
  • Sivaprasad S, Tschosik E, Kapre A, et al. Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the Phase 2 Mahalo study. Am J Ophthalmol. 2018;190:1–8. doi:10.1016/j.ajo.2018.03.006
  • Kimel M, Leidy NK, Tschosik E, et al. Functional Reading Independence (FRI) Index: a new patient-reported outcome measure for patients with geographic atrophy. Invest Ophthalmol Vis Sci. 2017;57(14):6298. doi:10.1167/iovs.16-20361
  • Rovner BW, Casten RJ, Massof RW, Leiby BE, Tasman WS; Wills Eye A.M.D. Study. Psychological and cognitive determinants of vision function in age-related macular degeneration. Arch Ophthalmol. 2011;129(7):885–890. doi:10.1001/archophthalmol.2011.146
  • Woo SJ, Park KH, Ahn J, et al. Cognitive impairment in age-related macular degeneration and geographic atrophy. Ophthalmology. 2012;119(10):2094–2101. doi:10.1016/j.ophtha.2012.04.026
  • Schmier JK, Covert DW, Lau EC. Patterns and costs associated with progression of age-related macular degeneration. Am J Ophthalmol. 2012;154(4):675–681.e671. doi:10.1016/j.ajo.2012.04.017
  • U.S. Bureau of Labor Statistics. Medical care in U.S. city average, all urban consumers, not seasonally adjusted. Available from: https://data.bls.gov/timeseries/CUUR0000SAM?output_view=pct_12mths. Accessed December 1, 2019.
  • Deb P, Norton EC. Modeling health care expenditures and use. Annu Rev Public Health. 2018;39(1):489–505. doi:10.1146/annurev-publhealth-040617-013517
  • Mihaylova B, Briggs A, O’Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20(8):897–916. doi:10.1002/hec.1653
  • Gray A, Clarke PM, Wolstenholme J. Applied Methods of Cost-Effectiveness Analysis in Health Care. Oxford, England: Oxford University Press; 2010.
  • Dodd S, Bassi A, Bodger K, Williamson P. A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract. 2006;12(1):76–86. doi:10.1111/j.1365-2753.2006.00610.x
  • Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–494. doi:10.1016/s0167-6296(01)00086-8
  • Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics. 2004;6(1):93–109. doi:10.1093/biostatistics/kxh020
  • Flaxel CJ, Adelman RA, Bailey ST, et al. Age-related macular degeneration Preferred Practice Pattern®. Ophthalmology. 2020;127(1):P1–P65. doi:10.1016/j.ophtha.2019.09.024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.